sdz mrl 953 has been researched along with interleukin-8 in 2 studies
| Studies (sdz mrl 953) | Trials (sdz mrl 953) | Recent Studies (post-2010) (sdz mrl 953) | Studies (interleukin-8) | Trials (interleukin-8) | Recent Studies (post-2010) (interleukin-8) |
|---|---|---|---|---|---|
| 8 | 1 | 0 | 23,523 | 1,167 | 9,990 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engelhardt, R; Foster, C; Golenbock, D; Hildebrandt, J; Landmann, R; Mayer, P; Stern, A; Stütz, P | 1 |
| Engelhardt, R; Färber, L; Gaboriau, E; Galanos, C; Haus, U; Kiani, A; Knopf, HP; Mertelsmann, R; Otto, F; Seiz, A; Stütz, P; Tschiersch, A | 1 |
1 trial(s) available for sdz mrl 953 and interleukin-8
| Article | Year |
|---|---|
Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patients.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Cytokines; Double-Blind Method; Down-Regulation; Endotoxins; Humans; Interleukin-1; Interleukin-6; Interleukin-8; Lipid A; Lipopolysaccharides; Middle Aged; Neoplasms; Neutrophils; Prospective Studies; Salmonella; Tumor Necrosis Factor-alpha | 1997 |
1 other study(ies) available for sdz mrl 953 and interleukin-8
| Article | Year |
|---|---|
SDZ MRL 953, a lipid A analog as selective cytokine inducer.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; Cells, Cultured; Cytokines; Humans; In Vitro Techniques; Interleukin 1 Receptor Antagonist Protein; Interleukin-8; Lipid A; Lipopolysaccharide Receptors; Lipopolysaccharides; Macaca mulatta; Molecular Structure; Monocytes; Receptors, Interleukin-1; Sialoglycoproteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 1995 |